A dose-dependent pharmacokinetic study on caffeic acid in rabbits after intravenous administration
โ Scribed by Yow-Shieng Uang; Kuang-Yang Hsu
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 249 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
โฆ Synopsis
The dose-dependent pharmacokinetics of caeic acid (CA) were studied in rabbits. Three dierent doses (5, 10, and 25 mg kg 71 ) were administered intravenously to six rabbits each. The concentrationยฑtime proยฎles for CA could be ยฎtted by a twocompartment model for each dose. The results showed that total-body clearance and elimination rate constant from the central compartment (k 10 ) after a 5 mg kg 71 dose were greater than those after the other two doses. Furthermore, the terminal elimination half-life (b half-life) and mean residence time (MRT) after a 5 mg kg 71 dose were less than after the other doses. The AUC value increased linearly with dose within the range of 10ยฑ25 mg kg 71 . Most of the unchanged caeic acid was excreted in the urine within 2 h. The percentage of unchanged caeic acid excreted in the urine was 63ยด4, 60ยด0, and 55ยด4% after doses of 5, 10, and 25 mg kg 71 , respectively, which was not signiยฎcantly dierent. However, signiยฎcant dierences in the renal clearances and renal excretion rate constants were observed with a 5 mg kg 71 dose compared to the other doses. On the other hand, nonrenal clearances and nonrenal excretion rate constants showed no doserelated dierences. The dierences observed in total-body clearance, k 10 , b half-life, and MRT between a 5 mg kg 71 dose and the other doses can be explained on the basis of the dierences in renal clearance and renal excretion rate constants. &1997 John Wiley & Sons, Ltd.
๐ SIMILAR VOLUMES
The pharmacokinetics of valproic acid (VPA) was investigated in six healthy volunteers. This was done by monitoring total and free (unbound) valproic acid levels in the serum, and the amount of one of its metabolites, VPA glucuronide, in the urine as a function of time, after a single dose administr
Deacetyl diltiazem (M 1 ) is a major metabolite of the widely used calcium antagonist diltiazem (DTZ). In order to study the pharmacokinetic and haemodynamic effects of this metabolite, M 1 was administered as a single 5 mg kg -1 dose intravenously (iv) to New Zealand white rabbits (n = 5) via a mar
Acebutolol (AC) is a chiral b-adrenergic blocking drug, possessing intrinsic sympathomimetic activity (ISA), and is useful clinically as the racemate in treating hypertension. Utilizing a stereospeciยฎc high-performance liquid chromatographic (HPLC) assay, the enantiomeric disposition of AC and its m
Recombinant tissue-type plasminogen activator (rt-PA) is indicated for the treatment of acute myocardial infarction as a dose of up to 100 mg. Several clinical trials have suggested that higher patency rates can be achieved with a rapid drug administration. A study was conducted in rabbits to determ